article thumbnail

Mississippi provider org's use of telehealth enables huge turnaround during the pandemic

Healthcare IT News - Telehealth

Before shifting gears to telemedicine, the technology infrastructure of Southwest Mississippi Mental Health Complex in McComb, Mississippi, was very old and extremely limited. The last computers purchased across the agency were acquired in 2008. THE PROBLEM. "At best, services were offered telephonically. MARKETPLACE.

article thumbnail

How Hims & Hers built a business entirely centered on telehealth

Healthcare IT News - Telehealth

What was the strategy behind incorporating full-blown telemedicine into your business? Telemedicine has always been at the core of Hims & Hers' business. To receive medical care from licensed healthcare professionals, patients must provide personal data such as their medical history. And this is just the beginning.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

States and Feds Signal Big Changes to Telehealth Prescribing

Health Law Advisor

On February 14, 2023, the Utah Senate passed a bill that would repeal the State’s “Online Prescribing, Dispensing, and Facilitation Licensing Act” (“Online Prescribing Act”). Additional, but narrower and less common scenarios also qualify as the “practice of telemedicine” as defined in 21 U.S.C. § 18 U.S.C. § 18 U.S.C. §

article thumbnail

October-December 2021 State Regulatory Developments

New Jersey Healthcare Blog

This notice extends the waiver of the continuing education requirements for current active health officers and REHSs who are renewing their license for the 2022 licensing period. The rules include definitions for various levels of supervision and permitted tasks within the scope of the license. See N.J.A.C. 10:101 as N.J.A.C.

article thumbnail

Access to Abortion Pill on the Precipice: A Deep Dive into the Federal Court Rulings that will Decide the Fate of Mifepristone 

Healthcare Law Blog

Even though the FDA conducted a comprehensive scientific analysis of Mifepristone, and the Government Accountability Office published a 2008 report finding that FDA operated within their authority under Subpart H to approve the drug, the District Court chose not to defer to the FDA’s expertise.

FDA 52
article thumbnail

Health Provider News

Hall Render

for physician referral scheme In Los Angeles, hospital CEO pay could be capped Kaiser Permanente ratings affirmed amid healthy financial profile Nurses vote ‘no confidence’ in California hospital administration, board Nursing facility, management company settle physician kickback allegations for $3.8M